depot naltrexone

DRUG5 trials

Sponsors

New York State Psychiatric Institute, University of Pennsylvania, US Department of Veterans Affairs

Conditions

Alcohol DependenceHeroin DependenceOpiate AddictionOpiate DependenceOpioid Dependence

Phase 2

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

CompletedNCT00332228

New York State Psychiatric InstituteOpiate Dependence

Start: 2002-06-30End: 2007-12-31Updated: 2012-10-26

Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site

CompletedNCT00781898

University of PennsylvaniaOpiate Addiction

Start: 2008-06-30End: 2015-08-31Updated: 2017-10-23

Phase 3

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

CompletedNCT00577408

New York State Psychiatric InstituteHeroin Dependence, Opiate Dependence

Start: 2007-09-30End: 2011-08-31Updated: 2017-08-25

Phase 4

Pilot Study of Depot NTX in Homeless Veterans

TerminatedNCT01155869

US Department of Veterans AffairsAlcohol Dependence

Start: 2010-08-31End: 2012-06-30Updated: 2014-07-17

Unknown Phase

Depot Naltrexone Treatment of Opioid Dependent Parolees

CompletedNCT00756990

University of PennsylvaniaOpioid Dependence

Start: 2005-11-30End: 2011-08-31Updated: 2019-04-23

Related Papers

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

New England Journal of Medicine2016-03-30310 citations

Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.

2015-01-1721 citations